Cargando…
Interleukin-1 receptor associated kinase 1/4 and bromodomain and extra-terminal inhibitions converge on NF-κB blockade and display synergistic antitumoral activity in activated B-cell subset of diffuse large B-cell lymphoma with MYD88 L265P mutation
| Autores principales: | , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Fondazione Ferrata Storti
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9713549/ https://www.ncbi.nlm.nih.gov/pubmed/36453521 http://dx.doi.org/10.3324/haematol.2022.281988 |
| _version_ | 1784842037596520448 |
|---|---|
| author | Dlouhy, Ivan Armengol, Marc Recasens-Zorzo, Clara Ribeiro, Marcelo L Pérez-Galán, Patricia Bosch, Francesc López-Guillermo, Armando Roué, Gaël |
| author_facet | Dlouhy, Ivan Armengol, Marc Recasens-Zorzo, Clara Ribeiro, Marcelo L Pérez-Galán, Patricia Bosch, Francesc López-Guillermo, Armando Roué, Gaël |
| author_sort | Dlouhy, Ivan |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9713549 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Fondazione Ferrata Storti |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-97135492022-12-12 Interleukin-1 receptor associated kinase 1/4 and bromodomain and extra-terminal inhibitions converge on NF-κB blockade and display synergistic antitumoral activity in activated B-cell subset of diffuse large B-cell lymphoma with MYD88 L265P mutation Dlouhy, Ivan Armengol, Marc Recasens-Zorzo, Clara Ribeiro, Marcelo L Pérez-Galán, Patricia Bosch, Francesc López-Guillermo, Armando Roué, Gaël Haematologica Errata Corrige Fondazione Ferrata Storti 2022-12-01 /pmc/articles/PMC9713549/ /pubmed/36453521 http://dx.doi.org/10.3324/haematol.2022.281988 Text en Copyright© 2022 Ferrata Storti Foundation https://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution Noncommercial License (by-nc 4.0) which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited. |
| spellingShingle | Errata Corrige Dlouhy, Ivan Armengol, Marc Recasens-Zorzo, Clara Ribeiro, Marcelo L Pérez-Galán, Patricia Bosch, Francesc López-Guillermo, Armando Roué, Gaël Interleukin-1 receptor associated kinase 1/4 and bromodomain and extra-terminal inhibitions converge on NF-κB blockade and display synergistic antitumoral activity in activated B-cell subset of diffuse large B-cell lymphoma with MYD88 L265P mutation |
| title | Interleukin-1 receptor associated kinase 1/4 and bromodomain and extra-terminal inhibitions converge on NF-κB blockade and display synergistic antitumoral activity in activated B-cell subset of diffuse large B-cell lymphoma with MYD88 L265P mutation |
| title_full | Interleukin-1 receptor associated kinase 1/4 and bromodomain and extra-terminal inhibitions converge on NF-κB blockade and display synergistic antitumoral activity in activated B-cell subset of diffuse large B-cell lymphoma with MYD88 L265P mutation |
| title_fullStr | Interleukin-1 receptor associated kinase 1/4 and bromodomain and extra-terminal inhibitions converge on NF-κB blockade and display synergistic antitumoral activity in activated B-cell subset of diffuse large B-cell lymphoma with MYD88 L265P mutation |
| title_full_unstemmed | Interleukin-1 receptor associated kinase 1/4 and bromodomain and extra-terminal inhibitions converge on NF-κB blockade and display synergistic antitumoral activity in activated B-cell subset of diffuse large B-cell lymphoma with MYD88 L265P mutation |
| title_short | Interleukin-1 receptor associated kinase 1/4 and bromodomain and extra-terminal inhibitions converge on NF-κB blockade and display synergistic antitumoral activity in activated B-cell subset of diffuse large B-cell lymphoma with MYD88 L265P mutation |
| title_sort | interleukin-1 receptor associated kinase 1/4 and bromodomain and extra-terminal inhibitions converge on nf-κb blockade and display synergistic antitumoral activity in activated b-cell subset of diffuse large b-cell lymphoma with myd88 l265p mutation |
| topic | Errata Corrige |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9713549/ https://www.ncbi.nlm.nih.gov/pubmed/36453521 http://dx.doi.org/10.3324/haematol.2022.281988 |
| work_keys_str_mv | AT dlouhyivan interleukin1receptorassociatedkinase14andbromodomainandextraterminalinhibitionsconvergeonnfkbblockadeanddisplaysynergisticantitumoralactivityinactivatedbcellsubsetofdiffuselargebcelllymphomawithmyd88l265pmutation AT armengolmarc interleukin1receptorassociatedkinase14andbromodomainandextraterminalinhibitionsconvergeonnfkbblockadeanddisplaysynergisticantitumoralactivityinactivatedbcellsubsetofdiffuselargebcelllymphomawithmyd88l265pmutation AT recasenszorzoclara interleukin1receptorassociatedkinase14andbromodomainandextraterminalinhibitionsconvergeonnfkbblockadeanddisplaysynergisticantitumoralactivityinactivatedbcellsubsetofdiffuselargebcelllymphomawithmyd88l265pmutation AT ribeiromarcelol interleukin1receptorassociatedkinase14andbromodomainandextraterminalinhibitionsconvergeonnfkbblockadeanddisplaysynergisticantitumoralactivityinactivatedbcellsubsetofdiffuselargebcelllymphomawithmyd88l265pmutation AT perezgalanpatricia interleukin1receptorassociatedkinase14andbromodomainandextraterminalinhibitionsconvergeonnfkbblockadeanddisplaysynergisticantitumoralactivityinactivatedbcellsubsetofdiffuselargebcelllymphomawithmyd88l265pmutation AT boschfrancesc interleukin1receptorassociatedkinase14andbromodomainandextraterminalinhibitionsconvergeonnfkbblockadeanddisplaysynergisticantitumoralactivityinactivatedbcellsubsetofdiffuselargebcelllymphomawithmyd88l265pmutation AT lopezguillermoarmando interleukin1receptorassociatedkinase14andbromodomainandextraterminalinhibitionsconvergeonnfkbblockadeanddisplaysynergisticantitumoralactivityinactivatedbcellsubsetofdiffuselargebcelllymphomawithmyd88l265pmutation AT rouegael interleukin1receptorassociatedkinase14andbromodomainandextraterminalinhibitionsconvergeonnfkbblockadeanddisplaysynergisticantitumoralactivityinactivatedbcellsubsetofdiffuselargebcelllymphomawithmyd88l265pmutation |